Gen-Plus really had a great year so far, actually its best after the MBO 2015. Since then we managed a full turnaround from an internal development service to a full-fledged CRDO operating in international waters. Our track records range from patent work-arounds to EU-registrations and comprise solutions for difficult client development projects comprising high-potent and narcotic formulations, derma and thin film programs with demanding skin analytics as well as complex API solubilization studies using a rational solvent casting procedure. Lately we took on board our precision medicine approach utilizing 2D/3D printing technology incl. ink design and filament extrusion.

Meet us at the CPhI in Madrid for your co-operation programs, make an appointment today!

Related Posts

  • Gen Plus @ European Drug Delivery Summit

    read more

  • In-vitro Permeation and Penetration Testing in Gen-Plus

    read more

  • Are you a GMP person?

    read more